Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial
The LancetPublished 1 August 2005
Shawn D. Aaron, Katherine L. Vandemheen, Wendy Ferris, Dean Fergusson, Elizabeth Tullis, David Haase
Citations236
SJR quartileQ1
SJR score12.11
SNIP22.72
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Antibiotic therapy directed by combination antibiotic susceptibility testing did not result in better clinical and bacteriological outcomes compared with Therapy directed by standard culture and sensitivity techniques.
Abstract
Antibiotic therapy directed by combination antibiotic susceptibility testing did not result in better clinical and bacteriological outcomes compared with therapy directed by standard culture and sensitivity techniques. The non-bactericidal effects of antibiotic therapy might play an important part in determining improvement in patients with cystic fibrosis pulmonary exacerbations.
Keywords
MedicineBiochemistry, Genetics and Molecular Biology
The LancetOutpatient antibiotic use in Europe and association with resistance: a cross-national database study
3,058 Citations2005Herman Goossens, Matus Ferech +2 more
Outpatient antibiotic use in 26 countries in Europe between Jan 1, 1997, and Dec 31, 2002 was investigated by calculating the number of defined daily doses (DDD) per 1000 inhabitants per day according to WHO anatomic therapeutic chemical classification and DDD measurement methodology, and the ecological association between antibiotic use and antibiotic resistance rates was assessed using Spearman's correlation coefficients.
JAMAUsers' Guides to the Medical Literature
2,178 Citations1994Roman Jaeschke
The patient is a 28-year-old man whose acute onset of shortness of breath and vague chest pain began shortly after completing a 10-hour auto trip, and the physician is very apprehensive about his symptoms.
JAMAUsers' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group
1,830 Citations1994Roman Jaeschke
You are back where you were in the previous article1 on diagnostic tests: in the library studying an article that will guide you in interpreting ventilation-perfusion (V/Q) lung scans.
JAMAEmpirical Evidence of Design-Related Bias in Studies of Diagnostic Tests
1,808 Citations1999Jeroen G. Lijmer
These data provide empirical evidence that diagnostic studies with methodological shortcomings may overestimate the accuracy of a diagnostic test, particularly those including nonrepresentative patients or applying different reference standards.
NatureQuorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms
1,509 Citations2000Pradeep K. Singh, Amy L. Schaefer +4 more
CHEST JournalThe Measurement of Dyspnea
1,298 Citations1984Donald A. Mahler, David H. Weinberg +2 more
The results indicate that dyspnea can receive a direct clinical rating that provides important information not disclosed by customary physiologic tests.
NaturePseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation
977 Citations2002Eliana Drenkard, Frederick M. Ausubel
It is found that antibiotic-resistant phenotypic variants of P. aeruginosa with enhanced ability to form biofilms arise at high frequency both in vitro and in the lungs of CF patients.
JAMAAzithromycin in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosa
952 Citations2003Lisa Saiman, Bruce C. Marshall +9 more
Azithromycin treatment was associated with improvement in clinically relevant end points and should be considered for patients with CF who are 6 years or older and chronically infected with P aeruginosa.
Journal of Clinical InvestigationThe application of biofilm science to the study and control of chronic bacterial infections
654 Citations2003William Costerton, Richard Veeh +4 more
The potential benefits of the application of the new methods and concepts developed by biofilm science and engineering to the clinical management of infectious diseases are discussed.
New England Journal of MedicineMultidetector-Row Computed Tomography in Suspected Pulmonary Embolism
637 Citations2005Arnaud Perrier, Pierre‐Marie Roy +9 more
The data indicate the potential clinical use of a diagnostic strategy for ruling out pulmonary embolism on the basis of D-dimer testing and multidetector-row CT without lower-limb ultrasonography and a larger outcome study is needed before this approach can be adopted.
Journal of Clinical InvestigationThe application of biofilm science to the study and control of chronic bacterial infections
624 Citations2003William Costerton, Richard Veeh +4 more
The LancetLong term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial
546 Citations2002A Equi, IM Balfour-Lynn +2 more
Journal of Clinical MicrobiologyClinically Feasible Biofilm Susceptibility Assay for Isolates of <i>Pseudomonas aeruginosa</i> from Patients with Cystic Fibrosis
394 Citations2004Samuel M. Moskowitz, Jessica M. Foster +2 more
The feasibility of adapting biofilm susceptibility methods to the clinical microbiology laboratory is demonstrated and opens the way to examining whether biofilm testing might be used to select more effective antibiotic combinations for CF airway infections than methods in current use.
CHEST JournalSusceptibility Testing of Pseudomonas aeruginosa Isolates and Clinical Response to Parenteral Antibiotic Administration
308 Citations2003Arnold L. Smith, Stanley B. Fiel +3 more
A retrospective analysis using data from patients in the placebo arm of a phase 3 trial of tobramycin solution for inhalation concluded that even if isolate antibiotic susceptibilities affect outcome, the impact would be small and not clinically relevant.
The Journal of PediatricsDefining a pulmonary exacerbation in cystic fibrosis
304 Citations2001Margaret Rosenfeld, Julia Emerson +5 more
It is hoped that the proposed PEx score might serve as a standardized outcome measure for future clinical trials in cystic fibrosis, allowing meaningful comparisons of study results.
American Review of Respiratory DiseaseReduction of Sputum <i>Pseudomonas aeruginosa</i> Density by Antibiotics Improves Lung Function in Cystic Fibrosis More than Do Bronchodilators and Chest Physiotherapy Alone
260 Citations1990Warren E. Regelmann, Greg R. Elliott +2 more
Patients with cystic fibrosis and moderate obstructive lung disease in pulmonary exacerbation are evaluated in a double-blind placebo-controlled trial to determine the contribution of antibiotic-mediated reduction in sputum bacterial density to clinical improvement.
American Journal of Respiratory and Critical Care MedicineMultiple Combination Bactericidal Antibiotic Testing for Patients with Cystic Fibrosis Infected with <i>Burkholderia cepacia</i>
239 Citations2000Shawn D. Aaron, Wendy Ferris +3 more
It is concluded that triple-antibiotic combinations are more likely than double and single antibiotic combinations to be bactericidal against B. cepacia in vitro.
New England Journal of MedicineManaging Antibiotic Resistance
203 Citations2000Richard P. Wenzel, Michael B. Edmond
One hundred years ago, the three major causes of death in the United States were tuberculosis, pneumonia, and gastrointestinal infections; subsequently, the advent of antibiotics resulted in a majo...
Clinical Infectious DiseasesAntibiotic Susceptibility of Multiply Resistant Pseudomonas aeruginosa Isolatedfrom Patients with Cystic Fibrosis, Including Candidates for Transplantation
166 Citations1996Lisa Saiman, Farah Mehar +5 more
Administration of aerosolized aminoglycosides and synergy testing of antimicrobial combinations may represent viable therapeutic options for patients with CF.
Journal of Clinical MicrobiologySingle and Combination Antibiotic Susceptibilities of Planktonic, Adherent, and Biofilm-Grown <i>Pseudomonas aeruginosa</i> Isolates Cultured from Sputa of Adults with Cystic Fibrosis
142 Citations2002Shawn D. Aaron, Wendy Ferris +4 more
It is concluded that biofilm-grown bacteria derived from patients with CF show decreased susceptibility to the bactericidal effects of antibiotic combinations than do adherent and planktonically grown bacteria.
The Journal of PediatricsComparison of a β-lactam alone versus β-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis
141 Citations1999Arnold L. Smith, Carl F. Doershuk +12 more
It is concluded that the combination of aβ-lactam and an aminoglycoside produces a longer clinical remission than a β- lactam alone and slightly better initial improvement.
RespirationOutcomes of Adults with Cystic Fibrosis Infected with Antibiotic-Resistant <i>Pseudomonas aeruginosa</i>
124 Citations2005Noah Lechtzin, Majnu John +4 more
Infection with multiple-antibiotic-resistant P. aeruginosa is associated with accelerated progression of cystic fibrosis, and has important implications for infection control strategies, antibiotic use and lung transplantation.
American Journal of Respiratory and Critical Care MedicineAdult Cystic Fibrosis Exacerbations and New Strains of <i>Pseudomonas aeruginosa</i>
119 Citations2003Shawn D. Aaron, Karam Ramotar +8 more
It is concluded that for the majority of adult patients with cystic fibrosis a new pulmonary exacerbation is not caused by the acquisition of a new strain of P. aeruginosa.
Antimicrobial Agents and ChemotherapySynergistic Activities of Macrolide Antibiotics against <i>Pseudomonas aeruginosa</i> , <i>Burkholderia cepacia</i> , <i>Stenotrophomonas maltophilia</i> , and <i>Alcaligenes xylosoxidans</i> Isolated from Patients with Cystic Fibrosis
109 Citations2002Lisa Saiman, Yunhua Chen +2 more
Azithromycin and clarithromyzin were paired with other antibiotics to test synergistic activity against 300 multidrug-resistant pathogens isolated from cystic fibrosis patients to find out which drugs inhibited which strains.
Antimicrobial Agents and ChemotherapyAntimicrobial Susceptibility and Synergy Studies of <i>Stenotrophomonas maltophilia</i> Isolates from Patients with Cystic Fibrosis
100 Citations2003Pablo Gabriel, Juyan Zhou +4 more
To determine appropriate treatment for patients with CF, it is important to monitor the prevalence, antimicrobial susceptibility, and clinical impact of S. maltophilia in this patient population.
American Journal of Respiratory and Critical Care MedicineMultiple Combination Bactericidal Antibiotic Testing for Patients with Cystic Fibrosis Infected with Multiresistant Strains of <i>Pseudomonas aeruginosa</i>
74 Citations2000Bianca J. Lang, Shawn D. Aaron +3 more
It is concluded that double-antibiotic combinations containing meropenem or high-dose tobramycin show the best bactericidal activity in vitro against multiresistant strains of P. aeruginosa.
Current Opinion in Pulmonary MedicineApproach to resistant gram-negative bacterial pulmonary infections in patients with cystic fibrosis
69 Citations2003Robert N. Chernish, Shawn D. Aaron
Therapy for antibiotic-resistant bacterial infections in cystic fibrosis involves the use of new laboratory methods (synergy testing or multiple-combination bactericidal testing) to optimize antibiotic treatment strategies.
Cochrane Database of Systematic ReviewsSingle versus combination intravenous antibiotic therapy for people with cystic fibrosis
67 Citations2014Heather Elphick, Nikki Jahnke
The meta-analysis did not demonstrate any significant differences between monotherapy and combination therapy, in terms of lung function; symptom scores; adverse effects; and bacteriological outcome measures, and the results should be interpreted cautiously.
Annals of OncologyUsing evaluations of diagnostic tests: Understanding their limitations and making the most of available evidence
46 Citations1999Jonathan J Deeks
This paper outlines the types of studies that are commonly used in the evaluation process and concentrates on evaluations that compare a new test with a reference standard, first by considering the biases these studies are susceptible to and secondly byconsidering the application of the results of evaluation from gynaecological cancer research.
Cochrane Database of Systematic ReviewsSingle versus combination intravenous antibiotic therapy for people with cystic fibrosis
17 Citations2001H. E Elphick, A Tan
The results of this systematic review of monotherapy versus combination therapy for pulmonary exacerbations in CF are inconclusive and the review raises important methodological issues.